• August 9, 2020

FDA calls iQOS meeting

The US Food and Drug Administration has published a Federal Register notice announcing a meeting of the Tobacco Products Scientific Advisory Committee (TPSAC) to discuss modified risk tobacco product (MRTP) applications submitted by Philip Morris Products (PMP).

The meeting, which is scheduled for January 24-25 at the FDA’s White Oak campus, was the subject of a Center for Tobacco Products (CTP) press note.

The committee is due to discuss scientific issues related to the MRTP applications submitted by PMP for its iQOS system and several Marlboro HeatSticks products, which are currently under scientific review by the FDA.

Requests for the presentation of oral comments at the TPSAC meeting have to be submitted by December 27.

Written comments have to be submitted by January 4.

More information is available at: https://www.federalregister.gov/documents/2017/11/09/2017-24379/tobacco-products-scientific-advisory-committee-notice-of-meeting